Dr. Wroblewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Rockville Pike
Bethesda, MD 20889Phone+1 301-319-7768
Education & Training
Tripler Army Medical CenterResidency, Internal Medicine, 1999 - 2002
Medical University of South CarolinaClass of 1999
Certifications & Licensure
HI State Medical License 2001 - 2026
MD State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsFDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia E. Kwitkowski, R. Angelo de Claro, Thomas Gwise
Quality of Life Research. 2020-02-25 - 1 citationsU.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained...E. Dianne Pulte, Tanya Wroblewski, Erik Bloomquist, Shenghui Tang, Ann T. Farrell
The Oncologist. 2019-05-01 - 20 citationsIbrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System.Connie Cheng, Daniel Woronow, Afrouz Nayernama, Tanya Wroblewski, S. Christopher Jones
Leukemia & Lymphoma. 2018-05-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
